Discussion
With the release of watchOS 7 and iOS 14, Apple Watch users will be able to view an estimate of their
6MWD in the Health app on their iPhone. Reliable weekly estimation of 6MWD may remove the need for
users to perform at-home 6MWTs and, given potentially low compliance with at-home testing, improve
long-term monitoring of functional capacity and endurance for at-risk individuals.
The e6MWD described here had comparable accuracy across design and validation data sets, with
consistency comparable to those of reference tests in the current study and reported by others. Under
11
normal, unprompted participant behavior (that is, undirected time spent wearing Apple Watch and normal
activity levels), the metric availability was over 90 percent (see table 2). For study participants for whom
continuous data were available (n = 703), the mean time between estimates was approximately nine days,
and 94 percent of participants had a mean time between estimates of less than two weeks. This suggests
that most users should have approximately weekly estimates, particularly in a setting such as a monitored
research study where participants are reminded to wear Apple Watch.
Users can optimize yield by wearing a calibrated Apple Watch daily across a representative range of
activities. In the absence of this device calibration, the iPhone-based walking speed metric or GPS from
both iPhone and Apple Watch can also be used to calibrate this metric. Most users (75 percent) achieved
this calibration within four weeks in the described studies. More information on calibrating Apple Watch "
can be found at support.apple.com/en-us/HT204516.
We developed the 6MWD algorithm to provide accurate estimates on low-capacity, potentially at-risk
individuals by designing and validating the algorithm in a population of older adults with reference 6MWD
within a clinically useful range and in the absence of any single comorbidity. The study populations used for
design and validation had prevalences of diabetes and osteoarthritis in line with those of the similarly aged
U.S. population; COPD and coronary artery disease may have been underweighted relative to expected
12
prevalence. Assistive-device usage during reference testing overall approximated that of the U.S.
13
population; although cane usage may have been slightly underrepresented.
14
Clinical applications of 6WMT (such as risk stratification and therapeutic response measurement) typically
utilize distances less than 500 meters across a variety of conditions, including heart failure, pulmonary
15
artery hypertension, chronic obstructive pulmonary disease, and cancer.8 Based on their level of fitness "
16 17
or age, many users may consistently have values of 500 meters, the maximum estimate supported by this
algorithm.
While equations predicting 6MWD are typically based on an individual’s height, weight, age, and potentially
other characteristics,
,
the e6MWD described here is an individualized estimation based on direct, sensor-
18 19
derived measurements; comparing e6MWD to reference equation-based predictions to inform a “percentage
of expected” may hold value beyond that of the e6MWD value in isolation. The absolute e6MWD may"
20
be useful for risk stratification in older adults. Yazdanyar et al. found that among community-dwelling older
adults, a 6MWD of less than 338 meters was associated with an increased risk of all-cause mortality.
2.
The approach and results presented aren’t without limitations. The data used was from proctored 6MWTs
using different course lengths to develop the e6MWD. While some reports suggest that course length has "
a statistically significant effect on 6MWD, most studies show that this difference isn’t clinically relevant
21
and that consistent course layout (for example, oval compared with “out and back”) has more impact on
6MWD.
,
Increased variability in low-capacity users was present, particularly those using walkers (data
22 23
not shown). Racial and ethnic diversity in the study population didn’t approximate the U.S. population;
however, prior studies in similarly aged populations haven’t found independent differences in 6MWD based
on race or ethnicity and haven’t recommended adjusting expected values based on these factors.
24